Article Details

Eli Lilly's efsitora alfa shows promise in Phase III T2D trials

Retrieved on: 2024-05-17 17:09:25

Tags for this article:

Click the tags to see associated articles and topics

Eli Lilly's efsitora alfa shows promise in Phase III T2D trials. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. Related Company Profiles. Eli Lilly and Co.

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo